作者： sarah

Chigasaki, Japan, Apr 24, 2025 - (JCN Newswire via SeaPRwire.com) - ULVAC, Inc. and ULVAC CRYOGENICS INC. have successfully developed a dilution refrigerator*1 designed for quantum computing applications. On April 4, 2025, the unit was installed at a leading quantum research institute*2 in Japan. This achievement marks a critical milestone in the development of the country’s first fully Japan-built quantum computer—realized using only domestically developed core components.Until now, Japan has faced the long-standing challenge of building a quantum computer entirely from domestically sourced technologies. ULVAC’s cryogenic solution, now operating as a core part of this quantum system, demonstrates Japan’s growing competitiveness in the global quantum race. Localized development enables flexible scalability, secure supply chains, and lower operational risks for users. Among these elements, the dilution refrigerator—ensuring a stable cryogenic environment essential for high-precision qubit operations—plays a vital role in enabling both deployment and long-term usability.This quantum computer will be publicly demonstrated at the Expo 2025 Osaka, Kansai, Japan during the “entangle moment - [quantum | earth | universe] × art”*3 event, to be held from August 14–20. Visitors will be able to interact with the system via the cloud, experiencing real-time quantum operations firsthand.A Fully Japan-Made Quantum ComputerThe new system integrates all major subsystems—including the refrigerator, control electronics, and qubit chips—based on technologies developed in Japan. ULVAC led the development of the dilution refrigerator, which provides a stable cryogenic temperature of approximately 10 mK over extended periods, essential for the precise and reliable operation of qubits.The development team overcame numerous engineering challenges, such as maximizing cooling efficiency, minimizing vibration, and managing thermal contraction under cryogenic conditions. These were addressed through custom flow path design, precision component fabrication, and advanced thermal-stress simulations. Through extensive prototyping and testing, the system achieved reliable and consistent cryogenic performance.In anticipation of future scaling, ULVAC adopted a modular architecture, allowing the system to evolve from laboratory environments to real-world quantum computing platforms. Additionally, all critical cryogenic and vacuum technologies—including dilution refrigerators, pulse tube cryocoolers, and vacuum components—are developed and manufactured in-house. This integrated supply chain ensures long-term availability and support, meeting both current and future demands from advanced research facilities.“It has been a great honor, as a cryogenic engineer, to contribute to the cooling of a quantum computer using technologies developed entirely in Japan. Seeing our dilution refrigerator operate at the forefront of quantum innovation is deeply rewarding. This project marks just the beginning—we are committed to continuously advancing cryogenic performance and reliability for the future of quantum computing.”- Dr. Masamichi Saitoh, Lead Engineer at ULVAC CRYOGENICS INC., who oversaw the development of the dilution refrigeratorFuture ProspectsULVAC’s dedication to advancing quantum computing goes beyond this domestic collaboration. As leading players in the global quantum ecosystem increasingly recognize its strengths, ULVAC is emerging as a key enabler of next-generation technologies. By leveraging its deep expertise in vacuum and cryogenic technologies developed in Japan, the company will continue to support the growth of scalable quantum infrastructure and contribute to solving critical challenges facing future society.*1 This research was partially supported by the Japan Science and Technology Agency (JST) under the Moonshot Research & Development Program. It falls under Moonshot Goal 6: “Realization of a fault-tolerant universal quantum computer that will revolutionize economy, industry, and security by 2050” (Program Director: Dr. Masahiro Kitagawa), part of the R&D project “Development of Integration Technologies for Superconducting Quantum Circuits” (Project Manager: Dr. Tsuyoshi Yamamoto), specifically the research theme “Development of Cryogenic Systems Specialized for Quantum Computing” led by Dr. Masamichi Saitoh (Project No. JPMJMS2067).*2 The dilution refrigerator was installed at the Center for Quantum Information and Quantum Biology, The University of Osaka.*3 Expo 2025 Osaka, Kansai, Japan “entangle moment - [quantum | earth | universe] × art”About ULVAC, Inc.Since its founding in 1952, ULVAC, Inc. has been a comprehensive vacuum equipment manufacturer, providing manufacturing equipment, components, analytical instruments, materials, and services based on its core technology—vacuum technology. Working with customers across a wide range of industries, including semiconductors, electronic components, displays, automotive, and pharmaceuticals, ULVAC is committed to driving cutting-edge innovation and creating new value. https://www.ulvac.co.jp/en/About ULVAC Cryogenics Inc.Since its founding in 1981, ULVAC Cryogenics Inc. has been engaged in the development, manufacturing, and sales of cryopumps and cryogenic equipment utilizing cryogenic and control technologies. The company was founded through the integration of the vacuum technology of Japan Vacuum Engineering Co., Ltd. (now ULVAC, Inc.) and the refrigeration technology of the U.S.-based Helix Technology Corporation (now Edwards Vacuum LLC). In Japan, ULVAC Cryogenics holds a 40% market share in cryopump sales. https://www.ulvac-cryo.com/?lang=enFor more information:ULVAC CRYOGENICS INC. Sales Planning DepartmentTEL +81-467-85-8884 / Mail cryokikaku@ml.ulvac.com Copyright 2025 JCN Newswire via SeaPRwire.com.

Kawasaki, Japan and San Jose, California, Apr 23, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited and Super Micro Computer, Inc. are deepening their strategic collaboration in AI computing to facilitate the secure application of generative AI within dedicated environments. As a result, the two companies, alongside the wider Fujitsu Group, today announced the launch of the PRIMERGY GX2570 M8s, a Supermicro OEM server product featuring a high-performance GPU, SupportDesk, a high-quality maintenance and operational support service for Supermicro products offering the world's first maintenance provision for the company's liquid-cooled and GPU servers, and Infrastructure Manager, an integrated management tool designed to simplify server administration. Starting in July 2025, Fujitsu will combine these OEM products, maintenance services, and integrated management tools with its Takane large language model (LLM) for enterprises, to offer a managed services for building generative AI infrastructure, allowing customers to leverage generative AI without the need to own the assets.The use of generative AI in handling confidential or personal information introduces risks such as unintended learning, data breaches, and compliance with internal data storage policies. As a result, a dedicated environment is often required, which requires significant computing power and various expertise. Therefore, there is a demand for servers equipped with high-performance GPUs, and for support for maintenance and operation, as well as management tools that easily support the stable operation of servers.The PRIMERGY GX2570 M8s is a server designed for large-scale generative AI applications and will be offered in two cooling configurations: a 10U air-cooled model and a 4U liquid-cooled model, both featuring the advanced NVIDIA HGX B200 GPU.The SupportDesk maintenance and operation support service will offer high-quality support for Supermicro servers provided by Fujitsu Group, including on-site response to addresses in Japan within approximately 2 hours achieved through a network of 4,000 experienced engineers at 700 engineer locations nationwide.The Infrastructure Manager integrated management tool simplifies the management of the server lifecycle, including deployment, monitoring, and updates, a key priority for enterprise companies. It enables integrated operation and management of Supermicro GPU-equipped servers and Fujitsu Group's existing PRIMERGY line of x86 servers, freeing up time for customers to focus on utilizing middleware and applications.The managed service provided by Fujitsu encompasses these OEM products, as well as maintenance, and integrated management services, in addition to generative AI models such as Takane, allowing customers to easily utilize generative AI infrastructure of the required size without owning the assets. Through the provision of this managed service, Fujitsu will enable customers to rapidly launch generative AI infrastructure, reduce infrastructure maintenance and management costs, and contribute to customers' generative AI utilization and business transformation.Kazushi Koga, Corporate Executive Officer, Fujitsu Limited, comments:“By strengthening its collaboration with Supermicro, Fujitsu has created a comprehensive managed service offering that combines OEM servers with high-performance GPUs for generative AI in dedicated environments, along with high-quality maintenance, integrated management services and the Takane LLM for enterprises. We are confident that this initiative is an innovative step toward promoting safe and secure generative AI utilization and will contribute to the expansion of our customers' businesses.”Charles Liang, president and CEO, Super Micro Computer, Inc., comments:“Supermicro is excited to continue its strong relationship with Fujitsu. We believe the combination of Supermicro’s 10U air-cooled model and a 4U liquid-cooled model, both featuring the advanced NVIDIA HGX B200 GPU family, with Fujitsu’s recognized global service offer customers a proven AI solution for the accelration of AI in the enterprise.”About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu Limited Public and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Apr 23, 2025 - (JCN Newswire via SeaPRwire.com) - Furuya Metal Co., Ltd. (Head office: Toshima-ku, Tokyo; President: Takahito Furuya; “Furuya Metal”) and Asahi Kasei Corp. (Head office: Chiyoda-ku, Tokyo; President and Representative Director: Koshiro Kudo; “Asahi Kasei”) have, in collaboration with Nobian Industrial Chemicals B.V. (Head office: Amersfoort, the Netherlands; Chief Executive Officer: Michael Koenig; “Nobian”) and Mastermelt Ltd (Head office: London, United Kingdom; Chief Executive Officer: Rick Reidinger; “Mastermelt”), embarked on a demonstration trial regarding the recycling of metals used for chlor-alkali*1 electrolysis cells and the electrodes within those cells (hereinafter, “cells and electrodes”). Through this initiative, Furuya Metal will strive to build an ecosystem in the chlor-alkali industry using rare metal recycling.Concept of cell and electrode metal recycling process undertaken through the four companies' collaborationRare metals such as iridium and ruthenium are used in the electrodes of chlor-alkali electrolysis cells. Excellent in aspects such as heat resistance, chemical resistance, and electrical conductivity, iridium and ruthenium are expanding in application as industrial materials in various industries, such as electronics, semiconductor, and even industries such as green hydrogen and energy. Furuya Metal has been handling these metals over a span of 40 years, from raw material procurement to ultra-high-purity refining technologies, as well as sophisticated processing technologies and recycling technologies and capabilities. This allows the company to supply many customers, gaining a high global share. Demand for iridium and ruthenium is rising year after year, and due to their high rarity, so far, Furuya Metal has been working on efficient use through recycling over many years to achieve stable supply of these metals.In the chlor-alkali industry, securing a stable supply of rare metals and efficient reuse are becoming issues of growing importance. Furuya Metal will contribute toward the establishment of a precious metal recycling process in the chlor-alkali industry through this initiative.In this initiative, first, Asahi Kasei will collect electrodes that have reached the end of their service life from Nobian. Next, at Mastermelt and Furuya Metal, separation of catalysts from electrodes and processing of separated catalysts in preparation for the next process will be carried out, and precious metals will be extracted from the separated catalysts and purified to a higher level. Then, Asahi Kasei will manufacture electrodes coated with catalysts that use these precious metals as raw materials (hereinafter, “recycled-catalyst electrodes”). Nobian will carry out chlor-alkali electrolysis using these recycled-catalyst electrodes, allowing resource circulation in the manufacturing of caustic soda and chlorine. In this way, the four companies will collaborate to promote the establishment of a recycling process that recovers and reuses metals—including precious metals—from used cells and electrodes.Furuya Metal will continue to provide an efficient and stable supply of iridium and ruthenium and expand the applications of iridium and ruthenium in even more industries to contribute to the development of a digital society and a green society.About Asahi Kasei Corp.For 50 years since commercializing its membrane process for chlor-alkali electrolysis in 1975, Asahi Kasei has earned a strong reputation among customers for offering superior operating performance and reliability as a supplier of all technological elements of the process. Global demand for chlor-alkali in 2024 was approximately 100 million tons*2, and Asahi Kasei’s chlor-alkali process has been adopted at more than 160 plants in 30 countries as of December 2024, with a cumulative order volume of over 30 million tons per year converted to 100% caustic soda, making Asahi Kasei a leading global process supplier. The membrane process for chlor-alkali electrolysis produces chlorine, hydrogen, and caustic soda by electrolyzing brine using ion-exchange membranes. It eliminates the need to use environmentally hazardous mercury or asbestos as process materials, and enables greater energy efficiency. The combination of low-voltage membranes and electrolyzers developed with advanced Asahi Kasei technology reduces CO2 emissions by lowering power consumption in the electrolysis process.*1 A process of electrolyzing sodium chloride solutions to produce chlorine and caustic soda, both of which are used for various end applications, including organic and inorganic materials, pharmaceuticals, soaps, and detergents.*2 2024 World Analysis – Chlor-Alkali – Appendix (August 4, 2023)For inquiries regarding this press release, please contact:General Affairs & CSR Department, Furuya Metal Co., Ltd.Telephone: +81-3-5977-3377E-mail: ir@furuyametals.co.jpPress release: https://www.acnnewswire.com/docs/files/20250423_EN.pdf  Copyright 2025 JCN Newswire via SeaPRwire.com.

KAWASAKI, Japan, Apr 22, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited and RIKEN today announced the development of a world-leading 256-qubit superconducting quantum computer, established at the RIKEN RQC-FUJITSU Collaboration Center. This new quantum computer builds upon the advanced technology of the 64-qubit iteration, launched with the support of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(1) in October 2023, and incorporates newly-developed high-density implementation techniques. This announcement marks another crucial step toward the practical application of superconducting quantum computers and unlocking their potential to grapple with some of the world’s most complex issues.Both organizations will integrate the 256-qubit superconducting quantum computer into its platform for hybrid quantum computing lineup and offer it to companies and research institutions globally starting in the first quarter of fiscal 2025. The platform's expansion from 64 to 256 qubits empowers users to tackle more complex challenges, including the analysis of larger molecules and the implementation and demonstration of sophisticated error correction algorithms.Moving forward, both organizations will further enhance the platform's usability by working to enable seamless collaboration between quantum and classical computers, enabling the efficient execution of hybrid quantum-classical algorithms.Fujitsu and RIKEN’s 256-qubit superconducting quantum computer overcomes some key technical challenges, including appropriate cooling within the dilution refrigerator which is achieved through the incorporation of high-density implementation and cutting-edge thermal design. Other key features include:1. Scalable 3D connection structureEnables efficient scaling of qubit count without requiring complex redesigns by arranging 4-qubit unit cells in a 3D configurationThe 256-qubit machine utilizes the same unit cell design established in its 64-qubit predecessor, effectively demonstrating the scalability of this architectural approach2. Quadrupled implementation density within dilution refrigeratorQuadrupled implementation density achieved within the dilution refrigerator, allowing the 256-qubit machine to operate within the same cooling unit as the 64-qubit systemHighly optimized design that carefully balances heat generation from control circuits with the cooling capacity of the refrigerator, while maintaining the necessary ultra-high vacuum and extremely low temperaturesFuture PlansFujitsu is committed to accelerating the practical application of quantum computers from both hardware and software perspectives. Through its platform for hybrid quantum computing, Fujitsu will provide larger-scale quantum computers to global companies and research institutions conducting joint research in various fields, including finance and drug discovery.Fujitsu and RIKEN will continue R&D efforts toward the launch of a 1,000-qubit computer, which is scheduled to be installed in a new building at Fujitsu Technology Park in 2026. In addition, the two organizations will extend the installation period of their Collaboration Center from March 2025 to March 2029, and will continue to work on the long-term R&D of technologies that will enable the realization of even larger superconducting quantum computers.[1]Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology:Quantum Leap Flagship Program (Q-LEAP) "Research and Development of Superconducting Quantum Computers (Research Representative: Yasunobu Nakamura) Grant No. JPMXS0118068682."About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more : www.fujitsu.com.About RIKENRIKEN, a National Research and Development Agency, is Japan's largest comprehensive research institution renowned for high-quality research in a diverse range of scientific disciplines. Founded in 1917, initially as a private research foundation, RIKEN has grown rapidly in size and scope, today encompassing a network of world-class research centers and institutes across Japan.Website: www.riken.jp/en/.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiriesRIKENRIKEN Global CommunicationsTel: +81-(0)48-462-1225E-mail: pr@riken.jp Copyright 2025 JCN Newswire via SeaPRwire.com.

DELHI, Apr 22, 2025 - (JCN Newswire via SeaPRwire.com) - Olympus Medical Systems India Pvt. Ltd. (OMSI), an Olympus Group company, today announces the successful inauguration of newly constructed washrooms at eight government schools across major locations in India. This milestone is part of OMSI’s corporate social responsibility (CSR) initiative, the Water, Sanitation, and Hygiene (WASH) Program. By actively supporting community well-being and education through long-standing projects, OMSI and Olympus Corporation (Olympus), remain dedicated to supporting the next-generation education in India.Inauguration Ceremony at Government Middle School, Aklimpur, in Sohna Block of Gurugram District of Haryana, IndiaThe WASH Program, a decade-long CSR project by OMSI, focuses on enhancing school infrastructure by constructing and renovating washrooms to ensure that students—especially girls—have access to clean and safe sanitation facilities. This initiative addresses critical challenges in sanitation, hygiene, and child health that directly impact education. Several reports highlight that one in four girls in India drop out of school due to inadequate toilet facilities, underscoring the vital importance of this initiative for promoting gender equality and educational continuity.  Over its fiscal year which ended in March 2025, the 10th year since the program began, OMSI constructed washrooms in eight government schools across four major locations—Delhi NCR, Kolkata, Chennai, and Mumbai. —This initiative provides improved sanitation facilities for over 2,700 students and ensures better hygiene standards for the school communities. The inauguration for these schools took place in March 2025, attended by OMSI leaders, school headmasters, and other officials. Over the past decade, the company has contributed to creating hygienic learning environments for approximately 7,000 students across 30 schools through this program.Nutrition kits handed over by Naoshi Kikumoto, Managing Director, OMSIAdditionally, OMSI’s Olympus Arogya Bachpan (Disease-Free Childhood) Program, provided health check-ups, distributed nutrition kits, and held awareness sessions on essential topics such as personal hygiene and safety for approximately 450 students across two schools. This program, initiated in 2018, aims to improve student well-being through hygiene education, child safety awareness, and health check-ups, helping to combat malnutrition and instill lifelong healthy habits.  Since its establishment in 2009, OMSI has remained committed to enhancing health, hygiene, and awareness through these activities, positively impacting thousands of children across India and enabling them to pursue their education in a safe and hygienic environment.  “We at Olympus believe that every child deserves the opportunity to grow up healthy and to receive a quality education. Through our CSR programs, we are proud to contribute to a brighter, healthier future for children and communities across India," said Naoshi Kikumoto, Managing Director, OMSI.  Together with Olympus, OMSI will continue advancing global corporate citizenship to make people's lives healthier, safer, and more fulfilling across India and beyond.  Olympus’ Other CSR activities in India:Beyond its ongoing efforts in areas of hygiene and sanitation, OMSI also played a crucial role in supporting India’s healthcare infrastructure. In its fiscal year which ended in March 2025, the company supported the Saairaam Cancer Foundation in Salem, Tamil Nadu, and JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research), Pondicherry, by donating a Laparoscopic System and contributing to ENT (ear, nose and throat) cancer screening initiatives, respectively. These efforts aim to enhance cancer awareness, early detection, and treatment in underserved regions.   During the COVID-19 pandemic, in its fiscal year ended in March 2021 and 2022, OMSI supported Civil Hospital Gurgaon, with Antigen Test Kits, Viral Transport Medium Kits, canopy tents for testing camps, and rental vehicles for transporting samples and lab technicians. The company also donated a fully equipped ambulance, solar lights and other essentials to support the Earth Saviours Foundation. Furthermore, OMSI focused on strengthening infrastructure at Primary Healthcare Centers (PHCs) in remote areas across the country. It also provided basic sanitation facilities at government hospitals in severely affected regions lacking such services.   About Olympus   At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp. Also visit LinkedIn page of OMSI.For media inquiries, please contact:Sanjana GroverOlympus Medical Systems India Pvt Ltdsanjana.grover@olympus.comhttps://www.olymcpus.in/ Public Relations GroupOlympus CorporationGlobal-Public_Relations@olympus.comhttps://www.olympus-global.com/Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com Copyright 2025 JCN Newswire via SeaPRwire.com.

Kawasaki, Japan and Naples, Italy, Apr 18, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited and AKOS AI today announced that Fujitsu has provided the Italy-based startup with AI Trust technologies, consisting of five core tools from its Fujitsu Kozuchi AI service. These technologies will enable AKOS’s AI governance platform AKOS HUB, to offer EU AI Act compliance, risk management and general AI governance services and solutions to enterprise customers.AKOS AI offers AKOS HUB, which provides a set of packages of no-code/low-code tools and AI governance, supporting organizations of all sizes and industries in ensuring fairness, robustness, and risk management. AKOS HUB is comprised of the following packages that leverage Fujitsu Kozuchi :1. AI Act Package: Simplifies EU AI Act complianceThis package is based on the AI Compliance Assistant. By answering a questionnaire users determine their AI system's risk level and receive a list of required actions. The system then creates a compliance report. AKOS HUB also offers packages for ISO 42001 compliance the international standard for AI management systems, and the AI Risk Management Framework (AI RMF) of the U.S. National Institute of Standards and Technology (NIST).2. AI Impact Assessment Package: Identifies risks based on ethical guidelinesThis package is based on the AI Ethics Impact Assessment. It evaluates AI systems by mapping components, identifying stakeholder interactions, and automatically pinpointing ethical risks. A comprehensive risk analysis table, based on EU guidelines and past incidents, is generated.3. AI Risk Assessment Package : Ensures the reliable and efficient implementation of AI system risk managementThis package is based on the AI Risk Management tool, which supports trustworthy AI development throughout its lifecycle, from planning to operation. It facilitates ethical risk identification, bias mitigation, and robust tracking of evidence for problem resolution and auditing. It ensures compliance with AI regulations (e.g., EU AI Act) and provides powerful visualization of AI projects for proactive governance.4. AI Fairness Package : Verifies and improves the fairness of AI modelsThis package is based on the Fujitsu AI Ethics for Fairness and mitigates AI bias across all phases using Fujitsu’s intersectional bias detection algorithm, ensuring fairness across multiple attributes (e.g., gender, age, ethnicity). It evaluates fairness and prediction accuracy, clarifying trade-offs for optimal model selection.5. LLM Package : Diagnose biases hidden within large language models from diverse perspectivesThis package is based on the LLM Bias Diagnosis and evaluates biases across LLMs on various ethical topics. Users can assess publicly available LLMs or their own LLM. Bias evaluation covers four Sustainable Development Goals areas: Climate Action, Gender Equality, Healthcare, and Education. It also provides services for evaluating LLMs based on OWASP security guidelines.Surya Josyula, Head of Business Incubation Division, Technology Strategy Unit, Fujitsu Limited, comments:“As an active contributor to several leading organizations including the Organization for Economic Cooperation and Development (OECD), and the Global Partnership on Artificial Intelligence (GPAI), and as a recent pledge to the Hiroshima AI Process International Code of Conduct, Fujitsu has taken the lead in collaborating closely with partners, standardization institutes and industry regulatory bodies dedicated to setting global standards for AI trust and ethics. Fujitsu is a technology pioneer, and our goal is to research, develop and deliver new solutions based on these standards and promote safe, secure and trustworthy AI for society”.Alberto De Lazzari, AKOS AI Chief Executive Officer and Co-Founder comments:“The increasing adoption of AI solutions presents companies with new challenges, such as the ethical and fair use of AI, which require sound governance practices. AKOS HUB, the AI Governance Platform, supports responsible AI by helping enterprises manage and oversee the legal, ethical, and operational aspects of AI.”The European Union AI Act, which came into force on August 1st, 2024, is the first comprehensive legal framework aimed at regulating AI within the EU. The Act classifies AI systems based on their risk levels, and its primary objectives are to ensure that AI systems safeguard individuals' health, safety, and fundamental rights, while addressing the risks posed by AI models.Future PlansFujitsu and AKOS AI recognize AI's potential as a catalyst for enterprise transformation and sustainable growth. The two companies’ vision is that AI is not only beneficial for people but also for the planet, ensuring a harmonious balance between innovation and environmental stewardship.Fujitsu and AKOS AI are also committed to developing secure AI systems to ensure the prevention of threats and attacks that could compromise the confidentiality, integrity, or availability of an AI model or system powered by AI. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO and CAMBRIDGE, Mass., Apr 18, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (lecanemab)  Marketing Authorization (MA) in the European Union (EU). This makes the medicine the first therapy that targets an underlying cause of Alzheimer’s disease (AD) to be granted a MA in the EU.1,2Lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment (MCI) and mild dementia due to AD (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or heterozygotes with confirmed amyloid pathology.1 The lecanemab MA applies to all 27 EU Member States as well as Iceland, Liechtenstein, and Norway.3Lecanemab is the only approved Aβ monoclonal antibody that preferentially binds and clears toxic protofibrils** (soluble Aβ aggregates), in addition to targeting and reducing Aβ plaques (insoluble Aβ aggregates).1,2,4-7 Protofibrils are a key toxic form of Aβ that accumulate in the brain and cause neuronal injury.4-10MCI due to AD and AD dementia currently affects an estimated 15.2 million and 6.9 million people in Europe, respectively.11 AD progresses in stages that increase in severity over time, and each stage of the disease presents different challenges for those living with AD and their care partners. There is a significant unmet need for new treatment options that slow down the progression of AD from its early stage and reduce the overall burden on people affected by AD and society.“Today’s decision makes lecanemab the first treatment option in the EU that can slow the progression of early Alzheimer's disease. We are proud that our about 40-year heritage in dementia has led to this important milestone, as we aim to be part of the solution for a better future for those impacted by this disease globally,” said Haruo Naito, Chief Executive Officer at Eisai. “Eisai is working collaboratively with national reimbursement authorities and healthcare providers to support access for those eligible for lecanemab as soon as possible, aiming to make an impact not only on patients but also on their caregiving families and society in the EU.”  “The approval of lecanemab by the European Commission marks the thirteenth approval of this important medicine, which has already benefitted thousands of patients in the United States, Japan and other regions of the world,” said Christopher A. Viehbacher, President and Chief Executive Officer at Biogen. “Lecanemab is the first treatment which showed that the reduction of the Aβ plaques in the brain is associated with the slowing of cognitive decline in patients at the early stage of the disease. This is a landmark advancement in a field where there has been no or little innovation in the past 20 years.”Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority. In the EU (excluding the Nordic countries), Eisai and Biogen will co-promote the medicine, with Eisai distributing the product as the MA Holder. In the Nordic countries, Eisai and BioArctic will co-promote the medicine, with Eisai distributing the product as MA Holder.* Apolipoprotein E is a protein involved in the metabolism of lipid in humans. It is implicated in AD. People with only one (heterozygous) or no copy (non-carriers) of the ApoE ε4 gene are less likely to experience ARIA than people with two ApoE ε4 copies (homozygous).2 ARIA is a recognized important side effect with lecanemab that involves swelling and potential bleeding in the brain.1,2**  Protofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of Aβ, having a primary role in the cognitive decline of this progressive, debilitating condition.7 Protofibrils cause injury to neurons in the brain which, in turn, can negatively impact cognitive function via multiple mechanisms,7 not only increasing the development of insoluble Aβ plaques but also increasing direct damage to brain cell membranes and the connections that transmit signals between nerve cells or nerve cells and other cells.8 It is believed the reduction of protofibrils may slow the progression of AD by reducing damage to neurons in the brain and cognitive dysfunction.8▼: This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. If you have any side effects, talk to your healthcare professional. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via your national reporting system. By reporting side effects, you can help provide more information on the safety of this medicine.For more information, visit https://www.eisai.com/news/2025/news202532.html. MEDIA CONTACTSEisaiEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@eisai.comBiogen Inc.Jack Cox+ 1-781-464-3260public.affairs@biogen.com Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Apr 18, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi Industrial Equipment Systems Co., Ltd. (HIES) has begun operating a next-generation power conditioner(1) called a Grid Forming Inverter (GFM), at its Narashino Works facility in Chiba Prefecture. This cutting-edge system helps stabilize electric power systems as global transition to renewable energy, by simulating the stabilizing effects once provided by large power plants.As renewable energy becomes a bigger part of the power mix, older systems that relied on heavy rotating generators are retiring, but they also provided valuable "inertia" that kept the grid stable during power fluctuation between demand and supply. GFM technology helps recreate inertia, supporting a reliable power supply for the future.Why This MattersElectricity must be supplied at a stable frequency to keep our power systems running smoothly -typically at 50 Hz or 60 Hz. Traditionally, large power plants helped maintain that frequency because their heavy turbines had "inertia," a natural resistance to sudden changes.As more renewable energy sources like solar and wind replace thermal power plants using fossil fuels, that inertia in power system is decreasing. These newer systems can't stabilize frequency in the same way, increasing the risk of frequency fluctuations or even blackouts.This is where GFMs come in. They simulate this lost inertia, helping to balance the grid and maintain a stable supply of electricity – even when demand suddenly changes, or renewable output fluctuates.About Grid Forming Inverters (GFM)Unlike conventional inverters that simply follow the power grid, GFMs can create and stabilize their own grid, working together with other units to form self-sustaining microgrids(2). This makes them important for supporting local energy systems, improving grid resilience and enabling carbon neutrality.Powering Narashino WorksNarashino Works now runs on a system that combines solar energy, battery storage and inverter technology to reduce CO₂ emissions and keep operations required in the emergency event– even during blackouts of utility grid.81.9 kW of solar power (54 kW new and 27.9 kW existing) is used for the system, expected to reduce greenhouse gas emissions by 39.2 tons of CO2 annually.A newly built AC microgrid, powered by paralleled three GFMs, keeps systems like water pumps (also made by HIES) and internal announce equipment running smoothly, even when solar power fluctuates.A DC microgrid uses solar energy more efficiently, stores surplus power in batteries and feeds it back into the plant, helping reduce conversion losses and saving energy.The system can operate independently during emergencies, strengthening Narashino Works' disaster resilience.Since DC power supply has an advantage in environmental performance, this system was selected for a carbon reduction subsidy from Japan's Ministry of the Environment.(3)(1) A device that converts DC power supplied from solar power generation systems, storage batteries, etc., into AC power that can be used in buildings, etc.(2) A system to develop small-scale power generation facilities within a facility or region and become self-sufficient in electricity(3) Ministry of the Environment: Selected for a subsidy for carbon dioxide emission control measures in fiscal 2024About Hitachi Industrial Equipment Systems Co., Ltd.Hitachi Industrial Equipment Systems enhances productivity across various industries – including data centers, batteries, electronics and semiconductors and pharmaceuticals – through high-efficiency products such as compressed air systems, grid edge solutions, drives and coding and marking equipment. Our innovative solutions and services integrate digital technology to drive customer success and contribute to a more sustainable society. We support customers throughout the entire product lifecycle, from maintenance to recycling. For more information on Hitachi Industrial Equipment Systems, please visit https://www.hitachi-ies.com/.For inquiries, please contactYoji IkedaHitachi Industrial Equipment Systems Co., Ltd.Power Transmission and Distribution Systems Division, Alternating Grid Development Projectikeda-youji@hitachi-ies.co.jp Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Apr 17, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Environmental & Chemical Engineering Co., Ltd. (MHIEC), a part of Mitsubishi Heavy Industries (MHI) Group, has received an order from the Bureau of Sewerage of the Tokyo Metropolitan Government (the Bureau of Sewerage) to rebuild the sewage sludge incineration facility at the Nambu Sludge Treatment Plant in Ota-ku. The construction order calls for replacement of the existing superannuated sewage sludge incineration system with the industry's first "energy-supply" (carbon-negative) incinerator. The new incinerator enables reduction in greenhouse gas (GHG) emissions and provides power generation capacity exceeding the incinerator's energy consumption volume, made possible using the waste heat from sewage sludge incineration. The contracted work is valued at 6.41 billion JPY (excluding taxes) and is scheduled for completion in March 2030.The newly developed energy-supply incinerator is the result of joint research launched in FY2023 between the Bureau of Sewerage and a sewerage plant manufacturer. MHIEC attained all six R&D targets relating to GHG emissions employing a proprietary technology that combines a fluidized bed incineration system equipped with combustion optimization control(Note1) and a high-efficiency binary power generation system(Note2). The Bureau of Sewerage placed the order with MHIEC in reflection of its high assessment of the practical viability of the Company's technology.MHIEC took over MHI's technological development capabilities in sludge treatment, along with its abundant expertise in the construction and operation of related facilities, in 2006. Today, based on its solid track record MHIEC is in a prime position to propose comprehensive solutions incorporating all aspects of plant construction and operation. The Company received the order for the first energy-supply (carbon-negative) incinerator following the Bureau of Sewerage's assessment of the practical applicability of this configuration. Going forward MHIEC will proactively propose additional measures for saving energy and curbing global warming through constructing sewage sludge treatment plants, aiming for further expansion of orders.(1) Combustion optimization control is a proprietary technology of MHIEC enabling optimized control of combustion using multiple measures of the sewage sludge incinerator's combustion status.(2) A binary power generation system, instead of directly using waste heat, transfers the waste heat to a separate heating medium having a lower boiling point than water; the gas generated through the heating medium (by heating and vaporization) is then used to drive a turbine. The term "binary" derives from the dual heating cycle involving the heat source system and medium system. The binary system is also employed in geothermal power generation applications, etc.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.